VACCINES

Encorium has performed over 40 vaccine studies involving more than 150,000 patients at over 450 international sites. Our expertise ranges from pre-IND, phase I through pivotal phase III and phase IV studies. We have worked with over 20 clients in the field of vaccine research and have helped design and conduct landmark studies in Avian Flu, Influenza, Rotavirus and Varicella Zoster.

Encorium provides valuable consulting to clients on clinical and operational challenges associated with vaccine drug development.

Encorium has the largest number of professionals in vaccine trials in Northern and Central Eastern Europe and access to large number of investigators with experience in both pediatric and adult vaccine studies. Furthermore Encorium has a network of key opinion leaders in vaccine trials.

Biodefense Vaccine Initiative

Encorium is part of the biodefense vaccine initiative providing integral strategy for developing vaccines against biologic agents with potential military and/or bioterrorism applications – initiative reflects long-standing commitment, knowledge and expertise in the development of biologics. We partner with industry and government sectors to develop effective vaccines for biodefense.

Therapeutic Area Experience in Vaccines:

Anthrax
Clostridium Botulinum (Live attenuated)
Haemophilus Influenzae Type B
Hepatitis B
Hepatitis C
Human Immunodeficiency Virus (HIV)
Influenza (Seasonal)
Influenza (H5N1-Avian Flu)
Meningococcal disease

Measels Mumps Rubella
Pneumococcus
Rotavirus
Therapeutic Vaccines
Tuberculosis
Varicella-Zoster (Shingles Prevention)
Venezuelan Equine Encephalitis
Yersinia Pestis (Plague)